CAR-T Cell Therapy for Multiple Myeloma - Michaela Liedtke, MD | MCRT Webcast Apr 24, 2021 

Carlos. There is one fda approved car t therapy called Abecma by BMS approved for relapsed/refractory myeloma patients who have had more than 4 prior lines of therapy. The next one that is likely for approval is the Janssen CAR T which may get approved in November but is currently still in clinical trials.

Does your son have a multiple myeloma specialist?

@@HealthTreeForMyeloma no

No he doesn't

We have a specialized team that can help with all your multiple myeloma questions, you can have access to that free service by contacting us here: support@healthtree.org As a friendly reminder, keep in mind that they cannot provide medical advice, but we can guide you on what you need.